YCBD (cbdMD, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by YCBD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-16 | William F Raines III | Director | A | — | — |
| 2026-04-16 | Kevin Charles Roe | Director | A | — | — |
| 2026-04-16 | Scott G. Stephen | Director | A | — | — |
| 2026-04-16 | Sibyl Nichole Swift | Director | A | — | — |
| 2026-04-16 | Bakari T. Sellers | Director | A | — | — |
| 2026-04-16 | Jeffrey H Porter | Director | A | — | — |
| 2025-12-19 | Clark R. Crosnoe | 10%+ Owner | Sell | — | — |
| 2025-12-02 | Thomas Ronan Kennedy | CEO and CFO | A | — | — |
| 2025-05-20 | Kevin Charles Roe | Director | A | — | — |
| 2025-05-20 | Scott G. Stephen | Director | A | — | — |
| 2025-05-20 | Jeffrey H Porter | Director | A | — | — |
| 2025-05-20 | Sibyl Nichole Swift | Director | A | — | — |
| 2025-05-20 | Bakari T. Sellers | Director | A | — | — |
| 2025-05-20 | William F Raines III | Director | A | — | — |
| 2025-05-08 | Kevin Charles Roe | Director | C | — | — |
| 2025-05-08 | Thomas Ronan Kennedy | CEO and CFO | C | — | — |
| 2025-05-08 | Jeffrey H Porter | Director | C | — | — |
| 2024-09-30 | Thomas Ronan Kennedy | CEO and CFO | Buy | — | — |
| 2024-09-25 | Thomas Ronan Kennedy | CEO and CFO | Buy | — | — |
| 2024-08-30 | William F Raines III | Director | A | — | — |
| 2024-04-03 | Bakari T. Sellers | Director | A | — | — |
| 2024-04-03 | Scott G. Stephen | Director | A | — | — |
| 2024-04-03 | William F Raines III | Director | A | — | — |
| 2024-04-03 | Sibyl Nichole Swift | Director | A | — | — |
| 2024-01-18 | Raymond Scott Coffman | 10%+ Owner | A | — | — |
| 2023-05-05 | Thomas Ronan Kennedy | Interim CEO and CFO | Buy | — | — |
| 2023-02-22 | Bakari T. Sellers | Director | A | — | — |
| 2023-02-22 | Sibyl Nichole Swift | Director | A | — | — |
| 2023-02-22 | William F Raines III | Director | A | — | — |
| 2023-02-22 | Scott G. Stephen | Director | A | — | — |
| 2022-08-11 | Raymond Scott Coffman | Director | A | — | — |
| 2022-08-11 | Sibyl Nichole Swift | Director | A | — | — |
| 2022-05-19 | Martin A. Sumichrast | Chairman, CEO | A | — | — |
| 2022-05-19 | Raymond Scott Coffman | Director | A | — | — |
| 2022-05-18 | Kevin MacDermott | President | A | — | — |
| 2022-04-19 | William F Raines III | Director | A | — | — |
| 2022-04-19 | Peter J. Ghiloni | Director | A | — | — |
| 2022-04-19 | Scott G. Stephen | Director | A | — | — |
| 2022-04-15 | Bakari T. Sellers | Director | A | — | — |
| 2022-03-02 | Martin A. Sumichrast | Chairman & CO-CEO | A | — | — |
| 2022-03-02 | Raymond Scott Coffman | CO-CEO, President, Director | A | — | — |
| 2022-01-03 | Martin A. Sumichrast | Chairman & CO-CEO | M | — | — |
| 2021-12-30 | Raymond Scott Coffman | CO-CEO, President, Director | A | — | — |
| 2021-12-30 | Martin A. Sumichrast | Chairman & CO-CEO | A | — | — |
| 2021-10-05 | Peter J. Ghiloni | Director | A | — | — |
| 2021-10-05 | Bakari T. Sellers | Director | A | — | — |
| 2021-10-05 | Scott G. Stephen | Director | A | — | — |
| 2021-10-05 | William F Raines III | Director | A | — | — |
| 2021-10-05 | Thomas Ronan Kennedy | CFO | MIXED | — | — |
| 2021-10-05 | Sim Farar | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | CEO and CFO | 513,722 | — |
| — | CO-CEO, President, Director | 48,801 | — |
| — | Director | 44,419 | — |
| — | Director | 26,707 | — |
| — | Director | 20,010 | — |
| — | 10%+ Owner | 17,875 | — |
| — | Chairman, CEO | 5,957 | — |
| — | Director | 4,412 | — |
| — | Director | 4,324 | — |
| — | Director | 4,145 | — |
| — | President | 2,761 | — |
| — | Director | 861 | — |
| — | Chief Revenue Officer | 490 | — |
| — | Director | 354 | — |
| — | President | 350 | — |
| — | CFO & COO | 144 | — |
| — | Director | 49 | — |
| — | Director | 19 | — |
| — | Director | 7 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the YCBD quote page; the site-wide leaderboard is on the insider transactions hub.